This inventor holds 1 USPTO granted patent. Top assignee: Academia Sinica. Active years: 2013.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2013
Title: **Chiao-En Chen: Innovator in Immunogenic Protein Carriers**
Introduction
Chiao-En Chen, hailing from Taichung County, Taiwan, is an accomplished inventor known for his contributions to the field of immunology. With a strong focus on the development of innovative protein carriers, Chen's work aims at enhancing immune responses through advanced scientific methods.
Latest Patents
Chiao-En Chen holds a patent for an "Immunogenic protein carrier containing an antigen presenting cell binding domain and a cysteine-rich domain." This patent details a protein carrier that integrates an antigen presenting cell binding domain along with a cysteine-rich domain. Additionally, it describes an immunoconjugate that comprises the protein carrier with antigens conjugated to multiple cysteine residues found in the cysteine-rich domain. The patent also outlines the creation of an immune composition containing this immunoconjugate and an adjuvant, emphasizing its uses in eliciting immune responses.
Career Highlights
Chen is affiliated with Academia Sinica, a renowned research institution in Taiwan. His work there has showcased his commitment to advancing the understanding of immune responses through innovative approaches. His dedication to research has positioned him as a prominent figure in the field of protein carrier technologies.
Collaborations
Throughout his career, Chiao-En Chen has collaborated with esteemed colleagues such as Jaulang Hwang and Chun-Cheng Lin. These partnerships have contributed significantly to the success of his research endeavors, fostering an environment of innovative thinking and shared scientific achievements.
Conclusion
Chiao-En Chen's contributions to the field of immunology through his patent on immunogenic protein carriers exemplify the potential of scientific innovation to address health challenges. His ongoing collaboration with fellow researchers continues to inspire advancements in immune response elicitation, further solidifying his status as an essential figure in modern scientific research.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
